VEGFA and neoplasm: MP0250 significantly inhibited tumor growth (35.5% T/C, p = 0.0139) to a similar extent to the VEGF-inhibiting DARPin® molecule ACO279 (Figure 2A, Supplementary Table 1) while the HGF inhibitor ACO278 had no effect.